Shandong Xinhua Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SHANDONG XINHUA
SHANDONG XINHUA has four approved drugs.
Drugs and US Patents for Shandong Xinhua
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shandong Xinhua | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 211886-002 | Jan 25, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Shandong Xinhua | IBUPROFEN | ibuprofen | TABLET;ORAL | 207095-001 | May 5, 2017 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Shandong Xinhua | IBUPROFEN | ibuprofen | TABLET;ORAL | 207095-002 | Aug 21, 2018 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Shandong Xinhua | IBUPROFEN | ibuprofen | TABLET;ORAL | 202413-001 | Nov 23, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Shandong Xinhua | SEVELAMER CARBONATE | sevelamer carbonate | TABLET;ORAL | 215998-001 | Oct 24, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Shandong Xinhua | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 211886-001 | Jan 25, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

